Cardiac stents in coronary artery disease
Pro Research Analysisby 
Searched over 200M research papers
Coronary Artery Disease and the Role of Cardiac Stents
Coronary artery disease (CAD) is a leading cause of illness and death worldwide, caused by the narrowing of coronary arteries due to plaque buildup. Cardiac stents are now a standard treatment, used to keep arteries open and maintain blood flow to the heart muscle, which is vital for preventing heart attacks and other complications Udriște2021Meads2000Ahadi2023.
Types of Coronary Stents: Bare-Metal, Drug-Eluting, and Bioresorbable
The evolution of stent technology has seen several generations, each improving patient outcomes and reducing complications. Bare-metal stents (BMS) were the first widely used, providing a scaffold to prevent artery collapse but often leading to restenosis (re-narrowing of the artery) due to tissue growth inside the stent Udriște2021Nicolas2022Stefanini2017+2 MORE.
Drug-eluting stents (DES) were developed to address this problem. These stents release medications that prevent excessive tissue growth, significantly lowering the risk of restenosis compared to BMS Udriște2021Nicolas2022Stefanini2017+3 MORE. Newer generations of DES have improved safety and effectiveness, with thinner struts, better polymers, and more effective drugs Nicolas2022Stefanini2017Iqbal2013.
Bioresorbable stents are the latest innovation, designed to dissolve over time, potentially reducing long-term complications, though more research is needed to confirm their long-term benefits Udriște2021Iqbal2013.
Effectiveness and Safety of Cardiac Stents in CAD
Clinical studies show that stent placement is more effective than balloon angioplasty alone, with higher procedural success, larger artery openings, and lower rates of restenosis Meads2000Fischman1994. Drug-eluting stents, in particular, are associated with fewer adverse heart events, such as the need for repeat procedures, heart attacks, and cardiac death, compared to bare-metal stents Ahmad2024Iqbal2013Serruys2006.
However, DES may carry a risk of late stent thrombosis (blood clots forming long after the procedure), so patients are usually prescribed dual anti-platelet therapy to reduce this risk Iqbal2013Serruys2006. The choice of stent and the duration of anti-platelet therapy remain areas of ongoing research and debate .
Special Considerations: Stents in Cardiac Allograft Vascular Disease
In patients with cardiac allograft vascular disease (a complication after heart transplantation), stenting can provide significant improvement in artery size and blood flow, with good short-term outcomes. However, restenosis can still occur, and long-term results depend on further advances in stent design and application .
Future Directions in Coronary Stent Technology
Research continues to focus on developing stents with better materials, more biocompatible coatings, and new drug combinations to further reduce complications and improve long-term outcomes. Simulation and biomechanical studies are helping to optimize stent design for better performance and safety Udriște2021Nicolas2022Stefanini2017+2 MORE.
Conclusion
Cardiac stents have revolutionized the treatment of coronary artery disease, offering effective and safe options for restoring blood flow and reducing the risk of heart attacks. Drug-eluting stents have become the preferred choice due to their lower rates of restenosis and adverse events. Ongoing research aims to further improve stent technology, making treatments even safer and more effective for patients with CAD.
Sources and full results
Most relevant research papers on this topic
Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
Stents are effective and cost-efficient in treating subacute ischaemic heart disease, particularly stable angina and unstable angina, and acute MI, but not in acute myocardial infarction.
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside.
New-generation drug-eluting coronary stents have improved safety and reduced in-stent restenosis, offering a more effective treatment for coronary artery disease.
State of the art: coronary artery stents - past, present and future.
Coronary stent technology has revolutionized heart disease treatment over the last 40 years, with advances in metallic stents, drug-eluting stents, and bare metal stents.
DOI